Production of Ginsenoside F2 by Using Lactococcus lactis with Enhanced Expression of β-Glucosidase Gene from Paenibacillus mucilaginosus
Authors:
- 5 November 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 64 (12) , 2506-2512
Abstract
This study aimed to produce a pharmacologically active minor ginsenoside F2 from the major ginsenosides Rb1 and Rd by using a recombinant Lactococcus lactis strain expressing a heterologous β-glucosidase gene. The nucleotide sequence of the gene (BglPm) was derived from Paenibacillus mucilaginosus and synthesized after codon optimization, and the two genes (unoptimized and optimized) were expressed in L. lactis NZ9000. Codon optimization resulted in reduction of unfavorable codons by 50% and a considerable increase in the expression levels (total activities) of β-glucosidases (0.002 unit/mL, unoptimized; 0.022 unit/mL, optimized). The molecular weight of the enzyme was 52 kDa, and the purified forms of the enzymes could successfully convert Rb1 and Rd into F2. The permeabilized L. lactis expressing BglPm resulted in a high conversion yield (74%) of F2 from the ginseng extract. Utilization of this microbial cell to produce F2 may provide an alternative method to increase the health benefits of Panax ginseng.Keywords
Funding Information
- Ministry of Science, ICT and Future Planning (2013M3A6A8073553)
- National Research Foundation of Korea (2015R1A2A2A01007156)
This publication has 32 references indexed in Scilit:
- Identification and Characterization of a Mucilaginibacter sp. Strain QM49 β-Glucosidase and Its Use in the Production of the Pharmaceutically Active Minor Ginsenosides ( S )-Rh 1 and ( S )-Rg 2Applied and Environmental Microbiology, 2013
- Evaluation of the food grade expression systems NICE and pSIP for the production of 2,5-diketo-D-gluconic acid reductase from Corynebacterium glutamicumAMB Express, 2013
- Enzymatic Biotransformation of Ginsenoside Rb1 and Gypenoside XVII into Ginsenosides Rd and F2 by Recombinant β-glucosidase from Flavobacterium johnsoniaeJournal of Ginseng Research, 2012
- Anti-Cancer Effect of Ginsenoside F2against Glioblastoma Multiforme in Xenograft Model in SD RatsJournal of Ginseng Research, 2012
- Biotransformation of Ginsenoside Rb1to Prosapogenins, Gypenoside XVII, Ginsenoside Rd, Ginsenoside F2, and Compound K by Leuconostoc mesenteroides DC102Journal of Ginseng Research, 2011
- Engineering lactic acid bacteria for increased industrial functionalityBioengineered Bugs, 2011
- Pharmacology of ginsenosides: a literature reviewChinese Medicine, 2010
- Efficient transformation of Lactococcus lactis IL1403 and generation of knock‐out mutants by homologous recombinationJournal of Basic Microbiology, 2007
- Periplasmic penicillin G acylase activity in recombinant Escherichia coli cells permeabilized with organic solventsProcess Biochemistry, 2003
- Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-κB activation and tumor promotionMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2003